Jeroen is a molecular biologist and biotechnology innovator with 18 years of experience in advanced genetic engineering and recombinant expression systems, including microbial, mammalian, and plant-based platforms. His expertise spans CRISPR-engineering, molecular design, and the translation of complex biological systems into scalable manufacturing solutions.

Over the past decade, he has focused intensively on plant molecular farming and transient expression technologies, driving significant advancements in the efficiency and economics of plant-made pharmaceutical production. His work has centered on reducing operational expenditure through upstream process intensification, streamlined downstream purification strategies, and integrated bioprocess design.

Jeroen is the inventor of multiple patented technologies commercialized by SwiftPharma, including the HyperXpress™ transient expression system and proprietary platforms for the biomanufacture of bioengineered human collagens produced in plants. He has secured six granted patents and holds 11 additional patent families pending, covering innovations in expression technology, molecular engineering, biologics, and scalable plant-based biologics production.

His long-term mission is to establish plant-based biomanufacturing as a globally competitive, capital-efficient alternative to conventional biologics manufacturing platforms.